Here's Why Momentum Investors Will Love Alnylam Pharmaceuticals (ALNY)Zacks Investment Research • 12/13/19
Alnylam Continues To Deliver On RNAi Pipeline With Alternative Treatment Option For Rare DiseaseSeeking Alpha • 12/05/19
Alnylam Pharmaceuticals, Inc. (ALNY) Shares March Higher, Can It Continue?Zacks Investment Research • 11/26/19
Alnylam Pharmaceuticals Sheds Some Light On Its Expanding Early-Stage OpportunitiesSeeking Alpha • 11/26/19
Second RNAi Drug Approved: Biotech Investors Should Pay Attention to This New Drug ClassThe Motley Fool • 11/23/19
Alnylam Pharmaceuticals Secures Its Second Approval, And The Pipeline Is Still AttractiveSeeking Alpha • 11/21/19
Alnylam Pharmaceuticals' (ALNY) CEO John Maraganore on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/31/19
Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 10/31/19